CN114392340A - 一种祛风除湿的草本泥膏及其制作方法 - Google Patents
一种祛风除湿的草本泥膏及其制作方法 Download PDFInfo
- Publication number
- CN114392340A CN114392340A CN202210102908.8A CN202210102908A CN114392340A CN 114392340 A CN114392340 A CN 114392340A CN 202210102908 A CN202210102908 A CN 202210102908A CN 114392340 A CN114392340 A CN 114392340A
- Authority
- CN
- China
- Prior art keywords
- parts
- wax
- herbal paste
- wind
- dampness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 31
- 239000001993 wax Substances 0.000 claims abstract description 26
- 235000019808 microcrystalline wax Nutrition 0.000 claims abstract description 22
- 239000004200 microcrystalline wax Substances 0.000 claims abstract description 22
- 230000003796 beauty Effects 0.000 claims abstract description 18
- 229920002367 Polyisobutene Polymers 0.000 claims abstract description 17
- 240000000249 Morus alba Species 0.000 claims abstract description 16
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 16
- 229940099259 vaseline Drugs 0.000 claims abstract description 16
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 15
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 15
- 241000244365 Ligusticum sinense Species 0.000 claims abstract description 15
- 235000006533 astragalus Nutrition 0.000 claims abstract description 15
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 15
- 230000000149 penetrating effect Effects 0.000 claims abstract description 15
- 235000013976 turmeric Nutrition 0.000 claims abstract description 15
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 13
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 239000003973 paint Substances 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000002844 melting Methods 0.000 claims description 5
- 230000008018 melting Effects 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000035807 sensation Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 241000125175 Angelica Species 0.000 claims description 3
- 241001061264 Astragalus Species 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 241000913745 Spatholobus Species 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 210000004233 talus Anatomy 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 5
- 230000003213 activating effect Effects 0.000 abstract description 4
- 229940126673 western medicines Drugs 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000002500 effect on skin Effects 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 208000017667 Chronic Disease Diseases 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010005963 Bone formation increased Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000011275 Epicondylitis Diseases 0.000 description 1
- 244000062245 Hedychium flavescens Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000028571 Occupational disease Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000011232 storage material Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 239000005335 volcanic glass Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种祛风除湿的草本泥膏及其制作方法,属于膏药技术领域,解决了目前通过推拿治疗风寒湿气无法根治并且服用西药存在副作用等技术问题。解决方案为:一种祛风除湿的草本泥膏及其制作方法,包括以下重量份数的组分:微晶蜡220~300份、美容蜡120~150份、火山泥100~220份、凡士林50~80份、聚异丁烯50~150份、热感剂5~8份、渗透剂20~30份、桑枝30~50份、鸡血藤50~80份、黄芪20~40份、当归30~50份、黄姜50~80份、川穹20~30份。本发明中各个组分安全,通过相互之间的协同作用,相辅相成,治疗效果快,具有活血、抗炎、祛风除湿的多重功效,能迅速打通人体经络,将人体内的风寒湿邪驱出体外,达到快速治愈顽疾的目的;安全、对皮肤无副作用,标本兼治。
Description
技术领域
本发明属于膏药技术领域,具体涉及的是一种祛风除湿的草本泥膏及其制作方法。
背景技术
颈、肩、腰、腿及四肢关节疼痛,是一种非常常见的病症,尤以中老年人发病率高。上述病症大多由于肝肾不足,痰滞血瘀;气血不足,生理失调引起。此外,人的筋骨随年龄增长而退化,致肌筋拘挛、僵硬,骨质增生,最终造成临床症状的产生。临床症状大多表现为:颈椎病、肩周炎、网球肘、腰间盘突出、骨质增生等。上述症状增加了患者生理上的痛苦,大大降低了患者的生活质量,严重者导致患者丧失劳动能力。并且随着社会进步发展,采用电脑进行伏案工作的人越来越多,由于现代人们运动较少,身体活动量比较小,越来越多的人患有职业病的困扰,并且很容易受到空调风等风寒影响,身体常常不舒服。
目前,对于上述症状一般采用西药治疗或者推拿治疗,推拿治疗只能起到病情缓解的作用,无法进行根治,并且推拿都得找专业人员进行推拿,费时费力,而西药一般具有副作用,不适合长期服用。
发明内容
本发明的目的在于克服现有技术的缺点,提供一种祛风除湿的草本泥膏及其制作方法,解决了目前通过推拿治疗风寒湿气无法根治并且服用西药存在副作用等技术问题。
为了解决上述问题,本发明的技术方案为:一种祛风除湿的草本泥膏及其制作方法,其中:包括以下重量份数的组分:微晶蜡220~300份、美容蜡120~150份、火山泥100~220份、凡士林50~80份、聚异丁烯50~150份、热感剂5~8份、渗透剂20~30份、桑枝30~50份、鸡血藤50~80份、黄芪20~40份、当归30~50份、黄姜50~80份、川穹20~30份。
进一步,包括以下重量份数的组分:微晶蜡250~280份、美容蜡130~140份、火山泥140~180份、凡士林60~70份、聚异丁烯80~120份、热感剂6~7份、渗透剂23~27份、桑枝35~45份、鸡血藤60~70份、黄芪25~35份、当归35~45份、黄姜60~70份、川穹23~27份。
进一步,包括以下重量份数的组分:微晶蜡265份、美容蜡135份、火山泥160份、凡士林65份、聚异丁烯100份、热感剂6.5份、渗透剂25份、桑枝40份、鸡血藤65份、黄芪30份、当归40份、黄姜65份、川穹25份。
一种祛风除湿的草本泥膏的制作方法,其中:包括以下步骤:
1)按重量份分别称取微晶蜡、美容蜡、火山泥、凡士林、聚异丁烯、热感剂、渗透剂份、桑枝、鸡血藤、黄芪、当归、黄姜、川穹备用;
2)将称取好的微晶蜡和美容蜡混合,然后进行文火融化,融化为液体状态后,得到混合蜡,再加入其余组分;
3)对步骤2)中的混合物进行加热搅拌至全部混合均匀,直至无气泡,得到草本泥膏,然后在盛放盒中进行灌装和包装。
草本泥膏的使用方法:
1)打开放置有草本泥膏的盛放盒,将其放入微波炉,高火加热1.5~2分钟;
2)将步骤1)中加热后的草本泥膏用勺子搅拌均匀,降温至皮肤能够接受的温度待用;
3)将降温后的草本泥膏均匀涂抹于患处,厚度约0.5cm;
4)用保鲜膜将患处裹住,敷20~45分钟;
5)敷完沿着边缘卷起,放保鲜盒常温保存。
草本泥膏的感光指标:
项目 | 要求 |
形态 | 膏体 |
气味 | 中药的混合气味 |
杂质 | 无明显肉眼可见外来杂质 |
感光指标的试验方法:随即抽取草本泥膏200g,将其置放于盘内,在室内自然光下观察其色泽、形态、杂质,嗅其气味。
草本泥膏的理化指标:
项目 | 指标 |
PH值 | 5.0~7.0 |
汞(以Hg计)mg/kg | <1 |
砷(以As计)mg/kg | <2 |
镉(以Cd计)mg/kg | <5 |
铅(以Pb计)mg/kg | <10 |
草本泥膏的贮存要求:应贮存在温度-1℃~40℃,相对湿度不超过80%,无腐蚀性气体和通风良好的室内。
本发明中的部分组分的分析如下:
微晶蜡:微晶蜡是一种近似微晶性质的精制合成蜡,具有光泽好,熔点高,色泽浅的特点,其结构紧密,坚而滑润,能与各种天然蜡互熔,并能提高其低度蜡的熔点,改进粗性蜡的性能。微晶蜡本身洁白如玉,磨擦生光,对生产淡色制品带来极有利的影响。微晶蜡有很好的吸油性能,可和多种溶剂、蜡类形成稳定、均匀的膏体,并有乳化性。
火山泥:火山泥的成分主要以火山玻璃为主要成分的深灰到黑色的无黏性泥为主,火山泥蕴含三十多种微量元素和矿物质:硅、铝、镁、钙、铁、钛、硫、磷、钠、铜、锌、硒、钴、锰、钼等,具有可以美白、淡化色斑、消炎、杀菌、激活皮肤细胞、消除脸色暗黄,使皮肤组织再生的功能。并且通过火山泥强力的吸咐与活血化淤作用,可以达到美白肌肤且调节人体微循环的目的,同时火山泥中的各种矿物与微量元素会被人体吸收,对人体脏器与关节均有修复功能。
凡士林:主要为化学惰性的碳氢化合物,并没有杀菌能力;但它不亲水、不会被吸收,涂抹在皮肤上能在其表面形成一层膜,使水分不易蒸发散失,可以保持皮肤为湿润状态,阻挡来自空气中的细菌和皮肤接触,从而降低感染的可能性。
聚异丁烯:聚异丁烯是合成高分子,可作为药物的储库或载体材料,调节药物的释放速度,具有生物相容性,对皮肤无刺激性,不引起过敏反应,具有足够强的粘附力和内聚强度,化学性质稳定,对温度与湿气稳定,且有能粘接不同类型皮肤的适应性,能容纳一定量的药物与经皮吸收促进剂而不影响化学稳定性与粘附力。
热感剂:常温下为黄色透明液体,不溶于水,溶于乙醇和油脂中,对皮肤具有热感效果,热感持久。
桑枝:味微苦,性平;归肝经,祛风湿而善达四肢经络,通利关节,痹证新久、寒热均可应用,尤宜于风湿热痹,肩臂、关节酸痛麻木者;有较强的抗炎活性,可提高人体淋巴细胞转化率,具有增强免疫的作用。
鸡血藤:味苦、微甘,性温;归肝、肾经,行血养血,舒筋活络,治疗经脉不畅,络脉不和病证。
黄芪:味甘,性微温;归脾、肺经。补气固表,托毒排脓,利尿,生肌。
当归:味甘、辛,性温;归肝、心、脾经,补血活血,调经止痛。
黄姜:味苦;微甘;性凉;清肺止咳;利湿通淋;通络止痛;解毒消肿。
川穹:对大肠、痢疾、变形、绿脓、伤寒、副伤寒杆菌及霍乱弧菌等有抑制作用。川芎水浸剂对某些致病性皮肤真菌也有抑制作用。
本发明的有益效果:
本发明中各个组分安全,通过相互之间的协同作用,相辅相成,治疗效果快,具有活血、抗炎、祛风除湿的多重功效,能迅速打通人体经络,将人体内的风寒湿邪驱出体外,达到快速治愈顽疾的目的;安全、对皮肤无副作用,标本兼治。
具体实施方式
下面通过实施例,对本发明作进一步的详细描述。
实施例1
一种祛风除湿的草本泥膏及其制作方法,其中:包括以下重量份数的组分:微晶蜡220份、美容蜡120份、火山泥100份、凡士林50份、聚异丁烯50份、热感剂5份、渗透剂20份、桑枝30份、鸡血藤50份、黄芪20份、当归30份、黄姜50份、川穹20份。
实施例2
一种祛风除湿的草本泥膏及其制作方法,其中:包括以下重量份数的组分:微晶蜡250份、美容蜡130份、火山泥140份、凡士林60份、聚异丁烯80份、热感剂6份、渗透剂23份、桑枝35份、鸡血藤60份、黄芪25份、当归35份、黄姜60份、川穹23份。
实施例3
一种祛风除湿的草本泥膏及其制作方法,其中:包括以下重量份数的组分:微晶蜡265份、美容蜡135份、火山泥160份、凡士林65份、聚异丁烯100份、热感剂6.5份、渗透剂25份、桑枝40份、鸡血藤65份、黄芪30份、当归40份、黄姜65份、川穹25份。
实施例4
一种祛风除湿的草本泥膏及其制作方法,其中:包括以下重量份数的组分:微晶蜡280份、美容蜡140份、火山泥180份、凡士林70份、聚异丁烯120份、热感剂7份、渗透剂7份、桑枝45份、鸡血藤70份、黄芪35份、当归45份、黄姜70份、川穹27份。
实施例5
一种祛风除湿的草本泥膏及其制作方法,其中:包括以下重量份数的组分:微晶蜡300份、美容蜡150份、火山泥220份、凡士林80份、聚异丁烯150份、热感剂8份、渗透剂30份、桑枝50份、鸡血藤80份、黄芪40份、当归50份、黄姜80份、川穹30份。
一种祛风除湿的草本泥膏的制作方法,包括以下步骤:
1)按重量份分别称取微晶蜡、美容蜡、火山泥、凡士林、聚异丁烯、热感剂、渗透剂份、桑枝、鸡血藤、黄芪、当归、黄姜、川穹备用;
2)将称取好的微晶蜡和美容蜡混合,然后进行文火融化,融化为液体状态后,得到混合蜡,再加入其余组分;
3)对步骤2)中的混合物进行加热搅拌至全部混合均匀,直至无气泡,得到草本泥膏,然后在盛放盒中进行灌装和包装。
草本泥膏的使用方法:
1)打开放置有草本泥膏的盛放盒,将其放入微波炉,高火加热1.5~2分钟;
2)将步骤1)中加热后的草本泥膏用勺子搅拌均匀,降温至皮肤能够接受的温度待用;
3)将降温后的草本泥膏均匀涂抹于患处,厚度约0.5cm;
4)用保鲜膜将患处裹住,敷20~45分钟;
5)敷完沿着边缘卷起,放保鲜盒常温保存。
本草本泥膏临床研究经过两年半时间共随机收集了病人200例,年龄8岁至55岁,百分之九十五的患者人群敷用最多五次后痊愈,随访无复发。
个别临床病例情况:
1)董某某,54岁,太原小店区人,膝关节疼痛,敷用本草本泥膏三次后,患者自身感觉症状大大减轻,继续使用两次后,痊愈,随访两个月无复发;
2)王某某,18岁,阳曲县人,打篮球右胳膊肌肉拉伤,敷用本草本泥膏一次后,患者肌肉疼痛情况缓解,继续敷用三次后,痊愈,再打篮球,胳膊不受影响,后续无复发。
Claims (4)
1.一种祛风除湿的草本泥膏,其特征在于:包括以下重量份数的组分:微晶蜡220~300份、美容蜡120~150份、火山泥100~220份、凡士林50~80份、聚异丁烯50~150份、热感剂5~8份、渗透剂20~30份、桑枝30~50份、鸡血藤50~80份、黄芪20~40份、当归30~50份、黄姜50~80份、川穹20~30份。
2.根据权利要求1所述的一种祛风除湿的草本泥膏,其特征在于:包括以下重量份数的组分:微晶蜡250~280份、美容蜡130~140份、火山泥140~180份、凡士林60~70份、聚异丁烯80~120份、热感剂6~7份、渗透剂23~27份、桑枝35~45份、鸡血藤60~70份、黄芪25~35份、当归35~45份、黄姜60~70份、川穹23~27份。
3.根据权利要求2所述的一种祛风除湿的草本泥膏,其特征在于:包括以下重量份数的组分:微晶蜡265份、美容蜡135份、火山泥160份、凡士林65份、聚异丁烯100份、热感剂6.5份、渗透剂25份、桑枝40份、鸡血藤65份、黄芪30份、当归40份、黄姜65份、川穹25份。
4.根据权利要求1~3任一所述一种祛风除湿的草本泥膏的制作方法,其特征在于:包括以下步骤:
1)按重量份分别称取微晶蜡、美容蜡、火山泥、凡士林、聚异丁烯、热感剂、渗透剂份、桑枝、鸡血藤、黄芪、当归、黄姜、川穹备用;
2)将称取好的微晶蜡和美容蜡混合,然后进行文火融化,融化为液体状态后,得到混合蜡,再加入其余组分;
3)对步骤2)中的混合物进行加热搅拌至全部混合均匀,直至无气泡,得到草本泥膏,然后在盛放盒中进行灌装和包装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210102908.8A CN114392340A (zh) | 2022-01-27 | 2022-01-27 | 一种祛风除湿的草本泥膏及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210102908.8A CN114392340A (zh) | 2022-01-27 | 2022-01-27 | 一种祛风除湿的草本泥膏及其制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114392340A true CN114392340A (zh) | 2022-04-26 |
Family
ID=81233624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210102908.8A Pending CN114392340A (zh) | 2022-01-27 | 2022-01-27 | 一种祛风除湿的草本泥膏及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114392340A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103565988A (zh) * | 2012-07-25 | 2014-02-12 | 天津太平洋制药有限公司 | 一种治疗风湿性关节炎的药物 |
CN108126170A (zh) * | 2017-12-27 | 2018-06-08 | 张兆波 | 一种中药泥灸膏及其制备方法 |
CN112168872A (zh) * | 2020-11-10 | 2021-01-05 | 深圳市和御道健康管理有限公司 | 一种中药热灸膏及其制备方法 |
-
2022
- 2022-01-27 CN CN202210102908.8A patent/CN114392340A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103565988A (zh) * | 2012-07-25 | 2014-02-12 | 天津太平洋制药有限公司 | 一种治疗风湿性关节炎的药物 |
CN108126170A (zh) * | 2017-12-27 | 2018-06-08 | 张兆波 | 一种中药泥灸膏及其制备方法 |
CN112168872A (zh) * | 2020-11-10 | 2021-01-05 | 深圳市和御道健康管理有限公司 | 一种中药热灸膏及其制备方法 |
Non-Patent Citations (2)
Title |
---|
李丽,等: "速效止痛酊治疗软组织损伤794例临床观察", 《长春中医学院学报》 * |
陈解兴: "手法、药沙袋治疗臀上皮神经损伤75例", 《实用医学杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106620370A (zh) | 一种治疗脚气的中药 | |
CN106729586A (zh) | 一种多功能草本能量灸药膏及其使用方法 | |
CN106474444A (zh) | 一种外用中药药包配方、药包及其使用方法 | |
CN107184782A (zh) | 外用中药组合物、制备方法及其应用 | |
CN105687587B (zh) | 温经通络止痛膏 | |
CN109568427A (zh) | 一种活血化瘀、软筋散结、缓解肌肉劳损、改善疲劳疼痛的中药提取制剂 | |
CN105031408B (zh) | 一种改善痛风的组合物 | |
CN103495145A (zh) | 一种中药百草足浴粉 | |
CN107536909A (zh) | 一种治疗筋骨疼痛和结节囊肿的药物及其制备方法 | |
CN104826082A (zh) | 一种用于治疗手足皲裂的药膏 | |
CN109381501A (zh) | 一种红花艾草泡脚保健粉及其制备方法 | |
CN101690703A (zh) | 一种美白祛斑的中药体膜及其制备方法 | |
CN114392340A (zh) | 一种祛风除湿的草本泥膏及其制作方法 | |
CN103977367A (zh) | 一种治疗气滞癖血型褥疮的中药及制备方法 | |
KR20170064672A (ko) | 허브 찜질액 및 그 제조방법 | |
CN105412864A (zh) | 一种用于治疗腰椎间盘突出症的祛痛膏 | |
CN105031170A (zh) | 一种保健足浴粉及其制备方法 | |
CN1994380B (zh) | 治疗痹症的外用中药药物及其热敷袋和制备方法 | |
CN108653631A (zh) | 一种涂抹式膏药及其制备方法 | |
CN116327866B (zh) | 一种畲泥灸祛风湿理疗方工艺 | |
WO2013185299A1 (zh) | 一种治疗类风湿关节炎的中药组合物及制备方法 | |
CN102028916B (zh) | 用于治疗腰腿痛的鸡骨威灵香汤 | |
CN106955314A (zh) | 活血清热川黄散 | |
CN106343092A (zh) | 一种养肝益精茶凉茶饮料及其制备方法 | |
CN1130207C (zh) | 骨伤膏及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220426 |
|
RJ01 | Rejection of invention patent application after publication |